Outcomes of Patients After Allo-HSCT With Decitabine and NAC

Decitabine (20mg/m2 intravenously from day -10 to day -8 of conditional regimen)

Acetylcysteine: 1.2g twice a day, oral administration, from day -10 to day 365 after HSCT.

Semustine: 250 mg/m2/day on day -9.

Cytarabine: 2 g/m2 every 12 hours on day -8.

Busulfan: 3.2mg/kg/day on day -7 to -5.

Cyclophosphamide: 1.8g/m2/day on day -4 to -3.

Cyclosporin A: 3mg/kg/d from day -8.

Anti-thymocyte globulin (2mg/kg/d on day -5 to day -2) will be added for transplants with unrelated donor or HLA mismatched donor.

Mycophenolate (500mg, oral, twice a day from day -8) will be added for transplants with unrelated donor or HLA mismatched donor.